These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25824109)

  • 1. Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases.
    Inoue K; Goto A; Kishimoto M; Tsujimoto T; Yamamoto-Honda R; Noto H; Kajio H; Terauchi Y; Noda M
    Clin Exp Nephrol; 2015 Dec; 19(6):1179-83. PubMed ID: 25824109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newer conversion equation for the correlation between HbA1c and glycated albumin.
    Inoue K; Tsujimoto T; Yamamoto-Honda R; Goto A; Kishimoto M; Noto H; Kajio H; Doi S; Miyazaki S; Terauchi Y; Noda M
    Endocr J; 2014; 61(6):553-60. PubMed ID: 24681757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.
    Ueda S; Nagai K; Yokota N; Hirose D; Mori H; Noma Y; Doi T; Minakuchi J
    J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.
    Tang M; Berg AH; Zheng H; Rhee EP; Allegretti AS; Nigwekar SU; Karumanchi SA; Lash JP; Kalim S
    Am J Kidney Dis; 2024 Sep; 84(3):329-338. PubMed ID: 38518919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Shima K; Chujo K; Yamada M; Komatsu M; Noma Y; Mizuguchi T
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):68-74. PubMed ID: 22194360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
    Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ
    Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct biomarker roles for HbA
    Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
    J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
    Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
    Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Performance characteristics of glycated albumin and its clinical usefulness in diabetic patients on hemodialysis].
    Park HI; Kim YS; Lee J; Kim Y; Shin SJ
    Korean J Lab Med; 2009 Oct; 29(5):406-14. PubMed ID: 19893349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin.
    Martino FG; Vitillo M; Pieri M; Marrone G; Gangeri F; Ansali F; Dessì M; Bernardini S; Di Daniele N; Noce A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.